Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 60 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 125 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 500 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - methylprednisolonum acetat - stungulyf, dreifa - 40 mg/ml

European Union - Icelandic - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - hydrocortisonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 100 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - hydrocortisonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 250 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - gemfibrozilum inn - filmuhúðuð tafla - 600 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg

Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg